Medical Care
Global Monoclonal Antibody Production Service Market Research Report 2024
- Jan 20, 24
- ID: 32870
- Pages: 101
- Figures: 228
- Views: 33
Monoclonal antibody production service refers to a specialized laboratory service that involves the production of monoclonal antibodies using various techniques such as cell fusion, immunization, and screening. This service typically involves the preparation of immune cells, fusion of these cells with immortalized cell lines, and screening of antibody-secreting clones to identify monoclonal antibodies that bind specifically to a desired target antigen. The service involves a range of procedures including antibody purification, characterization, and optimization to ensure the production of high-quality antibodies with desired properties.
The global Monoclonal Antibody Production Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for monoclonal antibody production service is towards increased demand in the pharmaceutical and biotechnology industries due to the growing need for advanced therapeutic and diagnostic tools. With the increasing use of monoclonal antibodies in oncology, autoimmune diseases, and other diseases, the need for reliable and efficient production services is increasing. Additionally, the trend towards more sustainable and environmentally friendly research and production methods is contributing to the growth of monoclonal antibody production services, as they reduce the use of harmful chemicals and minimize the environmental impact of antibody production. Furthermore, advancements in technology and bioinformatics are enabling more efficient and accurate production methods that are contributing to the increasing demand for monoclonal antibody production services.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Production Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Production Service.
Report Scope
The Monoclonal Antibody Production Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibody Production Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibody Production Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bon Opus Biosciences
Biomatik
ProSci, Inc
Sino Biological
Thermo Fisher Scientific
RayBiotech
Cygnus Technologies
Sino Biological
BosterBio
Abeomics
Merck
Cayman Chemical
Hycult Biotech
GenScript
ProMab
R&D Systems
Rockland Immunochemicals
ProteoGenix
Evitria
ProteoGenix
Beijing Abace Biotechnology
Zoonbio Biotechnology
Beijing Biosynthesis Biotechnology
Cusabio
ChinaPeptides
Detaibio
Atagenix Laboratories
Segment by Type
Rabbit Monoclonal Antibodies
Mouse Monoclonal Antibodies
Human Monoclonal Antibodies
Others
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Production Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Monoclonal Antibody Production Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for monoclonal antibody production service is towards increased demand in the pharmaceutical and biotechnology industries due to the growing need for advanced therapeutic and diagnostic tools. With the increasing use of monoclonal antibodies in oncology, autoimmune diseases, and other diseases, the need for reliable and efficient production services is increasing. Additionally, the trend towards more sustainable and environmentally friendly research and production methods is contributing to the growth of monoclonal antibody production services, as they reduce the use of harmful chemicals and minimize the environmental impact of antibody production. Furthermore, advancements in technology and bioinformatics are enabling more efficient and accurate production methods that are contributing to the increasing demand for monoclonal antibody production services.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Production Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Production Service.
Report Scope
The Monoclonal Antibody Production Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibody Production Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibody Production Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bon Opus Biosciences
Biomatik
ProSci, Inc
Sino Biological
Thermo Fisher Scientific
RayBiotech
Cygnus Technologies
Sino Biological
BosterBio
Abeomics
Merck
Cayman Chemical
Hycult Biotech
GenScript
ProMab
R&D Systems
Rockland Immunochemicals
ProteoGenix
Evitria
ProteoGenix
Beijing Abace Biotechnology
Zoonbio Biotechnology
Beijing Biosynthesis Biotechnology
Cusabio
ChinaPeptides
Detaibio
Atagenix Laboratories
Segment by Type
Rabbit Monoclonal Antibodies
Mouse Monoclonal Antibodies
Human Monoclonal Antibodies
Others
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Production Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Production Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rabbit Monoclonal Antibodies
1.2.3 Mouse Monoclonal Antibodies
1.2.4 Human Monoclonal Antibodies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Production Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Production Service Market Perspective (2019-2030)
2.2 Monoclonal Antibody Production Service Growth Trends by Region
2.2.1 Global Monoclonal Antibody Production Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Monoclonal Antibody Production Service Historic Market Size by Region (2019-2024)
2.2.3 Monoclonal Antibody Production Service Forecasted Market Size by Region (2025-2030)
2.3 Monoclonal Antibody Production Service Market Dynamics
2.3.1 Monoclonal Antibody Production Service Industry Trends
2.3.2 Monoclonal Antibody Production Service Market Drivers
2.3.3 Monoclonal Antibody Production Service Market Challenges
2.3.4 Monoclonal Antibody Production Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Production Service Players by Revenue
3.1.1 Global Top Monoclonal Antibody Production Service Players by Revenue (2019-2024)
3.1.2 Global Monoclonal Antibody Production Service Revenue Market Share by Players (2019-2024)
3.2 Global Monoclonal Antibody Production Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Production Service Revenue
3.4 Global Monoclonal Antibody Production Service Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Production Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Production Service Revenue in 2023
3.5 Monoclonal Antibody Production Service Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Production Service Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Production Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Production Service Breakdown Data by Type
4.1 Global Monoclonal Antibody Production Service Historic Market Size by Type (2019-2024)
4.2 Global Monoclonal Antibody Production Service Forecasted Market Size by Type (2025-2030)
5 Monoclonal Antibody Production Service Breakdown Data by Application
5.1 Global Monoclonal Antibody Production Service Historic Market Size by Application (2019-2024)
5.2 Global Monoclonal Antibody Production Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Monoclonal Antibody Production Service Market Size (2019-2030)
6.2 North America Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Monoclonal Antibody Production Service Market Size by Country (2019-2024)
6.4 North America Monoclonal Antibody Production Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Production Service Market Size (2019-2030)
7.2 Europe Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Monoclonal Antibody Production Service Market Size by Country (2019-2024)
7.4 Europe Monoclonal Antibody Production Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Production Service Market Size (2019-2030)
8.2 Asia-Pacific Monoclonal Antibody Production Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Production Service Market Size (2019-2030)
9.2 Latin America Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Monoclonal Antibody Production Service Market Size by Country (2019-2024)
9.4 Latin America Monoclonal Antibody Production Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Production Service Market Size (2019-2030)
10.2 Middle East & Africa Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bon Opus Biosciences
11.1.1 Bon Opus Biosciences Company Detail
11.1.2 Bon Opus Biosciences Business Overview
11.1.3 Bon Opus Biosciences Monoclonal Antibody Production Service Introduction
11.1.4 Bon Opus Biosciences Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.1.5 Bon Opus Biosciences Recent Development
11.2 Biomatik
11.2.1 Biomatik Company Detail
11.2.2 Biomatik Business Overview
11.2.3 Biomatik Monoclonal Antibody Production Service Introduction
11.2.4 Biomatik Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.2.5 Biomatik Recent Development
11.3 ProSci, Inc
11.3.1 ProSci, Inc Company Detail
11.3.2 ProSci, Inc Business Overview
11.3.3 ProSci, Inc Monoclonal Antibody Production Service Introduction
11.3.4 ProSci, Inc Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.3.5 ProSci, Inc Recent Development
11.4 Sino Biological
11.4.1 Sino Biological Company Detail
11.4.2 Sino Biological Business Overview
11.4.3 Sino Biological Monoclonal Antibody Production Service Introduction
11.4.4 Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.4.5 Sino Biological Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Monoclonal Antibody Production Service Introduction
11.5.4 Thermo Fisher Scientific Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 RayBiotech
11.6.1 RayBiotech Company Detail
11.6.2 RayBiotech Business Overview
11.6.3 RayBiotech Monoclonal Antibody Production Service Introduction
11.6.4 RayBiotech Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.6.5 RayBiotech Recent Development
11.7 Cygnus Technologies
11.7.1 Cygnus Technologies Company Detail
11.7.2 Cygnus Technologies Business Overview
11.7.3 Cygnus Technologies Monoclonal Antibody Production Service Introduction
11.7.4 Cygnus Technologies Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.7.5 Cygnus Technologies Recent Development
11.8 Sino Biological
11.8.1 Sino Biological Company Detail
11.8.2 Sino Biological Business Overview
11.8.3 Sino Biological Monoclonal Antibody Production Service Introduction
11.8.4 Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.8.5 Sino Biological Recent Development
11.9 BosterBio
11.9.1 BosterBio Company Detail
11.9.2 BosterBio Business Overview
11.9.3 BosterBio Monoclonal Antibody Production Service Introduction
11.9.4 BosterBio Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.9.5 BosterBio Recent Development
11.10 Abeomics
11.10.1 Abeomics Company Detail
11.10.2 Abeomics Business Overview
11.10.3 Abeomics Monoclonal Antibody Production Service Introduction
11.10.4 Abeomics Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.10.5 Abeomics Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Monoclonal Antibody Production Service Introduction
11.11.4 Merck Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.11.5 Merck Recent Development
11.12 Cayman Chemical
11.12.1 Cayman Chemical Company Detail
11.12.2 Cayman Chemical Business Overview
11.12.3 Cayman Chemical Monoclonal Antibody Production Service Introduction
11.12.4 Cayman Chemical Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.12.5 Cayman Chemical Recent Development
11.13 Hycult Biotech
11.13.1 Hycult Biotech Company Detail
11.13.2 Hycult Biotech Business Overview
11.13.3 Hycult Biotech Monoclonal Antibody Production Service Introduction
11.13.4 Hycult Biotech Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.13.5 Hycult Biotech Recent Development
11.14 GenScript
11.14.1 GenScript Company Detail
11.14.2 GenScript Business Overview
11.14.3 GenScript Monoclonal Antibody Production Service Introduction
11.14.4 GenScript Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.14.5 GenScript Recent Development
11.15 ProMab
11.15.1 ProMab Company Detail
11.15.2 ProMab Business Overview
11.15.3 ProMab Monoclonal Antibody Production Service Introduction
11.15.4 ProMab Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.15.5 ProMab Recent Development
11.16 R&D Systems
11.16.1 R&D Systems Company Detail
11.16.2 R&D Systems Business Overview
11.16.3 R&D Systems Monoclonal Antibody Production Service Introduction
11.16.4 R&D Systems Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.16.5 R&D Systems Recent Development
11.17 Rockland Immunochemicals
11.17.1 Rockland Immunochemicals Company Detail
11.17.2 Rockland Immunochemicals Business Overview
11.17.3 Rockland Immunochemicals Monoclonal Antibody Production Service Introduction
11.17.4 Rockland Immunochemicals Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.17.5 Rockland Immunochemicals Recent Development
11.18 ProteoGenix
11.18.1 ProteoGenix Company Detail
11.18.2 ProteoGenix Business Overview
11.18.3 ProteoGenix Monoclonal Antibody Production Service Introduction
11.18.4 ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.18.5 ProteoGenix Recent Development
11.19 Evitria
11.19.1 Evitria Company Detail
11.19.2 Evitria Business Overview
11.19.3 Evitria Monoclonal Antibody Production Service Introduction
11.19.4 Evitria Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.19.5 Evitria Recent Development
11.20 ProteoGenix
11.20.1 ProteoGenix Company Detail
11.20.2 ProteoGenix Business Overview
11.20.3 ProteoGenix Monoclonal Antibody Production Service Introduction
11.20.4 ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.20.5 ProteoGenix Recent Development
11.21 Beijing Abace Biotechnology
11.21.1 Beijing Abace Biotechnology Company Detail
11.21.2 Beijing Abace Biotechnology Business Overview
11.21.3 Beijing Abace Biotechnology Monoclonal Antibody Production Service Introduction
11.21.4 Beijing Abace Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.21.5 Beijing Abace Biotechnology Recent Development
11.22 Zoonbio Biotechnology
11.22.1 Zoonbio Biotechnology Company Detail
11.22.2 Zoonbio Biotechnology Business Overview
11.22.3 Zoonbio Biotechnology Monoclonal Antibody Production Service Introduction
11.22.4 Zoonbio Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.22.5 Zoonbio Biotechnology Recent Development
11.23 Beijing Biosynthesis Biotechnology
11.23.1 Beijing Biosynthesis Biotechnology Company Detail
11.23.2 Beijing Biosynthesis Biotechnology Business Overview
11.23.3 Beijing Biosynthesis Biotechnology Monoclonal Antibody Production Service Introduction
11.23.4 Beijing Biosynthesis Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.23.5 Beijing Biosynthesis Biotechnology Recent Development
11.24 Cusabio
11.24.1 Cusabio Company Detail
11.24.2 Cusabio Business Overview
11.24.3 Cusabio Monoclonal Antibody Production Service Introduction
11.24.4 Cusabio Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.24.5 Cusabio Recent Development
11.25 ChinaPeptides
11.25.1 ChinaPeptides Company Detail
11.25.2 ChinaPeptides Business Overview
11.25.3 ChinaPeptides Monoclonal Antibody Production Service Introduction
11.25.4 ChinaPeptides Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.25.5 ChinaPeptides Recent Development
11.26 Detaibio
11.26.1 Detaibio Company Detail
11.26.2 Detaibio Business Overview
11.26.3 Detaibio Monoclonal Antibody Production Service Introduction
11.26.4 Detaibio Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.26.5 Detaibio Recent Development
11.27 Atagenix Laboratories
11.27.1 Atagenix Laboratories Company Detail
11.27.2 Atagenix Laboratories Business Overview
11.27.3 Atagenix Laboratories Monoclonal Antibody Production Service Introduction
11.27.4 Atagenix Laboratories Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.27.5 Atagenix Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Production Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rabbit Monoclonal Antibodies
1.2.3 Mouse Monoclonal Antibodies
1.2.4 Human Monoclonal Antibodies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Production Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Production Service Market Perspective (2019-2030)
2.2 Monoclonal Antibody Production Service Growth Trends by Region
2.2.1 Global Monoclonal Antibody Production Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Monoclonal Antibody Production Service Historic Market Size by Region (2019-2024)
2.2.3 Monoclonal Antibody Production Service Forecasted Market Size by Region (2025-2030)
2.3 Monoclonal Antibody Production Service Market Dynamics
2.3.1 Monoclonal Antibody Production Service Industry Trends
2.3.2 Monoclonal Antibody Production Service Market Drivers
2.3.3 Monoclonal Antibody Production Service Market Challenges
2.3.4 Monoclonal Antibody Production Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Production Service Players by Revenue
3.1.1 Global Top Monoclonal Antibody Production Service Players by Revenue (2019-2024)
3.1.2 Global Monoclonal Antibody Production Service Revenue Market Share by Players (2019-2024)
3.2 Global Monoclonal Antibody Production Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Production Service Revenue
3.4 Global Monoclonal Antibody Production Service Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Production Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Production Service Revenue in 2023
3.5 Monoclonal Antibody Production Service Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Production Service Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Production Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Production Service Breakdown Data by Type
4.1 Global Monoclonal Antibody Production Service Historic Market Size by Type (2019-2024)
4.2 Global Monoclonal Antibody Production Service Forecasted Market Size by Type (2025-2030)
5 Monoclonal Antibody Production Service Breakdown Data by Application
5.1 Global Monoclonal Antibody Production Service Historic Market Size by Application (2019-2024)
5.2 Global Monoclonal Antibody Production Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Monoclonal Antibody Production Service Market Size (2019-2030)
6.2 North America Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Monoclonal Antibody Production Service Market Size by Country (2019-2024)
6.4 North America Monoclonal Antibody Production Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Production Service Market Size (2019-2030)
7.2 Europe Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Monoclonal Antibody Production Service Market Size by Country (2019-2024)
7.4 Europe Monoclonal Antibody Production Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Production Service Market Size (2019-2030)
8.2 Asia-Pacific Monoclonal Antibody Production Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Production Service Market Size (2019-2030)
9.2 Latin America Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Monoclonal Antibody Production Service Market Size by Country (2019-2024)
9.4 Latin America Monoclonal Antibody Production Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Production Service Market Size (2019-2030)
10.2 Middle East & Africa Monoclonal Antibody Production Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bon Opus Biosciences
11.1.1 Bon Opus Biosciences Company Detail
11.1.2 Bon Opus Biosciences Business Overview
11.1.3 Bon Opus Biosciences Monoclonal Antibody Production Service Introduction
11.1.4 Bon Opus Biosciences Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.1.5 Bon Opus Biosciences Recent Development
11.2 Biomatik
11.2.1 Biomatik Company Detail
11.2.2 Biomatik Business Overview
11.2.3 Biomatik Monoclonal Antibody Production Service Introduction
11.2.4 Biomatik Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.2.5 Biomatik Recent Development
11.3 ProSci, Inc
11.3.1 ProSci, Inc Company Detail
11.3.2 ProSci, Inc Business Overview
11.3.3 ProSci, Inc Monoclonal Antibody Production Service Introduction
11.3.4 ProSci, Inc Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.3.5 ProSci, Inc Recent Development
11.4 Sino Biological
11.4.1 Sino Biological Company Detail
11.4.2 Sino Biological Business Overview
11.4.3 Sino Biological Monoclonal Antibody Production Service Introduction
11.4.4 Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.4.5 Sino Biological Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Monoclonal Antibody Production Service Introduction
11.5.4 Thermo Fisher Scientific Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 RayBiotech
11.6.1 RayBiotech Company Detail
11.6.2 RayBiotech Business Overview
11.6.3 RayBiotech Monoclonal Antibody Production Service Introduction
11.6.4 RayBiotech Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.6.5 RayBiotech Recent Development
11.7 Cygnus Technologies
11.7.1 Cygnus Technologies Company Detail
11.7.2 Cygnus Technologies Business Overview
11.7.3 Cygnus Technologies Monoclonal Antibody Production Service Introduction
11.7.4 Cygnus Technologies Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.7.5 Cygnus Technologies Recent Development
11.8 Sino Biological
11.8.1 Sino Biological Company Detail
11.8.2 Sino Biological Business Overview
11.8.3 Sino Biological Monoclonal Antibody Production Service Introduction
11.8.4 Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.8.5 Sino Biological Recent Development
11.9 BosterBio
11.9.1 BosterBio Company Detail
11.9.2 BosterBio Business Overview
11.9.3 BosterBio Monoclonal Antibody Production Service Introduction
11.9.4 BosterBio Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.9.5 BosterBio Recent Development
11.10 Abeomics
11.10.1 Abeomics Company Detail
11.10.2 Abeomics Business Overview
11.10.3 Abeomics Monoclonal Antibody Production Service Introduction
11.10.4 Abeomics Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.10.5 Abeomics Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Monoclonal Antibody Production Service Introduction
11.11.4 Merck Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.11.5 Merck Recent Development
11.12 Cayman Chemical
11.12.1 Cayman Chemical Company Detail
11.12.2 Cayman Chemical Business Overview
11.12.3 Cayman Chemical Monoclonal Antibody Production Service Introduction
11.12.4 Cayman Chemical Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.12.5 Cayman Chemical Recent Development
11.13 Hycult Biotech
11.13.1 Hycult Biotech Company Detail
11.13.2 Hycult Biotech Business Overview
11.13.3 Hycult Biotech Monoclonal Antibody Production Service Introduction
11.13.4 Hycult Biotech Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.13.5 Hycult Biotech Recent Development
11.14 GenScript
11.14.1 GenScript Company Detail
11.14.2 GenScript Business Overview
11.14.3 GenScript Monoclonal Antibody Production Service Introduction
11.14.4 GenScript Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.14.5 GenScript Recent Development
11.15 ProMab
11.15.1 ProMab Company Detail
11.15.2 ProMab Business Overview
11.15.3 ProMab Monoclonal Antibody Production Service Introduction
11.15.4 ProMab Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.15.5 ProMab Recent Development
11.16 R&D Systems
11.16.1 R&D Systems Company Detail
11.16.2 R&D Systems Business Overview
11.16.3 R&D Systems Monoclonal Antibody Production Service Introduction
11.16.4 R&D Systems Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.16.5 R&D Systems Recent Development
11.17 Rockland Immunochemicals
11.17.1 Rockland Immunochemicals Company Detail
11.17.2 Rockland Immunochemicals Business Overview
11.17.3 Rockland Immunochemicals Monoclonal Antibody Production Service Introduction
11.17.4 Rockland Immunochemicals Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.17.5 Rockland Immunochemicals Recent Development
11.18 ProteoGenix
11.18.1 ProteoGenix Company Detail
11.18.2 ProteoGenix Business Overview
11.18.3 ProteoGenix Monoclonal Antibody Production Service Introduction
11.18.4 ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.18.5 ProteoGenix Recent Development
11.19 Evitria
11.19.1 Evitria Company Detail
11.19.2 Evitria Business Overview
11.19.3 Evitria Monoclonal Antibody Production Service Introduction
11.19.4 Evitria Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.19.5 Evitria Recent Development
11.20 ProteoGenix
11.20.1 ProteoGenix Company Detail
11.20.2 ProteoGenix Business Overview
11.20.3 ProteoGenix Monoclonal Antibody Production Service Introduction
11.20.4 ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.20.5 ProteoGenix Recent Development
11.21 Beijing Abace Biotechnology
11.21.1 Beijing Abace Biotechnology Company Detail
11.21.2 Beijing Abace Biotechnology Business Overview
11.21.3 Beijing Abace Biotechnology Monoclonal Antibody Production Service Introduction
11.21.4 Beijing Abace Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.21.5 Beijing Abace Biotechnology Recent Development
11.22 Zoonbio Biotechnology
11.22.1 Zoonbio Biotechnology Company Detail
11.22.2 Zoonbio Biotechnology Business Overview
11.22.3 Zoonbio Biotechnology Monoclonal Antibody Production Service Introduction
11.22.4 Zoonbio Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.22.5 Zoonbio Biotechnology Recent Development
11.23 Beijing Biosynthesis Biotechnology
11.23.1 Beijing Biosynthesis Biotechnology Company Detail
11.23.2 Beijing Biosynthesis Biotechnology Business Overview
11.23.3 Beijing Biosynthesis Biotechnology Monoclonal Antibody Production Service Introduction
11.23.4 Beijing Biosynthesis Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.23.5 Beijing Biosynthesis Biotechnology Recent Development
11.24 Cusabio
11.24.1 Cusabio Company Detail
11.24.2 Cusabio Business Overview
11.24.3 Cusabio Monoclonal Antibody Production Service Introduction
11.24.4 Cusabio Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.24.5 Cusabio Recent Development
11.25 ChinaPeptides
11.25.1 ChinaPeptides Company Detail
11.25.2 ChinaPeptides Business Overview
11.25.3 ChinaPeptides Monoclonal Antibody Production Service Introduction
11.25.4 ChinaPeptides Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.25.5 ChinaPeptides Recent Development
11.26 Detaibio
11.26.1 Detaibio Company Detail
11.26.2 Detaibio Business Overview
11.26.3 Detaibio Monoclonal Antibody Production Service Introduction
11.26.4 Detaibio Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.26.5 Detaibio Recent Development
11.27 Atagenix Laboratories
11.27.1 Atagenix Laboratories Company Detail
11.27.2 Atagenix Laboratories Business Overview
11.27.3 Atagenix Laboratories Monoclonal Antibody Production Service Introduction
11.27.4 Atagenix Laboratories Revenue in Monoclonal Antibody Production Service Business (2019-2024)
11.27.5 Atagenix Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Monoclonal Antibody Production Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Rabbit Monoclonal Antibodies
Table 3. Key Players of Mouse Monoclonal Antibodies
Table 4. Key Players of Human Monoclonal Antibodies
Table 5. Key Players of Others
Table 6. Global Monoclonal Antibody Production Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Monoclonal Antibody Production Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Monoclonal Antibody Production Service Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Monoclonal Antibody Production Service Market Share by Region (2019-2024)
Table 10. Global Monoclonal Antibody Production Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Monoclonal Antibody Production Service Market Share by Region (2025-2030)
Table 12. Monoclonal Antibody Production Service Market Trends
Table 13. Monoclonal Antibody Production Service Market Drivers
Table 14. Monoclonal Antibody Production Service Market Challenges
Table 15. Monoclonal Antibody Production Service Market Restraints
Table 16. Global Monoclonal Antibody Production Service Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Monoclonal Antibody Production Service Market Share by Players (2019-2024)
Table 18. Global Top Monoclonal Antibody Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Production Service as of 2023)
Table 19. Ranking of Global Top Monoclonal Antibody Production Service Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Monoclonal Antibody Production Service Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Monoclonal Antibody Production Service Product Solution and Service
Table 23. Date of Enter into Monoclonal Antibody Production Service Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Monoclonal Antibody Production Service Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Monoclonal Antibody Production Service Revenue Market Share by Type (2019-2024)
Table 27. Global Monoclonal Antibody Production Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Monoclonal Antibody Production Service Revenue Market Share by Type (2025-2030)
Table 29. Global Monoclonal Antibody Production Service Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Monoclonal Antibody Production Service Revenue Market Share by Application (2019-2024)
Table 31. Global Monoclonal Antibody Production Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Monoclonal Antibody Production Service Revenue Market Share by Application (2025-2030)
Table 33. North America Monoclonal Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Monoclonal Antibody Production Service Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Monoclonal Antibody Production Service Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Monoclonal Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Monoclonal Antibody Production Service Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Monoclonal Antibody Production Service Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Monoclonal Antibody Production Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Monoclonal Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Monoclonal Antibody Production Service Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Monoclonal Antibody Production Service Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Monoclonal Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2025-2030) & (US$ Million)
Table 48. Bon Opus Biosciences Company Detail
Table 49. Bon Opus Biosciences Business Overview
Table 50. Bon Opus Biosciences Monoclonal Antibody Production Service Product
Table 51. Bon Opus Biosciences Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 52. Bon Opus Biosciences Recent Development
Table 53. Biomatik Company Detail
Table 54. Biomatik Business Overview
Table 55. Biomatik Monoclonal Antibody Production Service Product
Table 56. Biomatik Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 57. Biomatik Recent Development
Table 58. ProSci, Inc Company Detail
Table 59. ProSci, Inc Business Overview
Table 60. ProSci, Inc Monoclonal Antibody Production Service Product
Table 61. ProSci, Inc Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 62. ProSci, Inc Recent Development
Table 63. Sino Biological Company Detail
Table 64. Sino Biological Business Overview
Table 65. Sino Biological Monoclonal Antibody Production Service Product
Table 66. Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 67. Sino Biological Recent Development
Table 68. Thermo Fisher Scientific Company Detail
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Monoclonal Antibody Production Service Product
Table 71. Thermo Fisher Scientific Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. RayBiotech Company Detail
Table 74. RayBiotech Business Overview
Table 75. RayBiotech Monoclonal Antibody Production Service Product
Table 76. RayBiotech Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 77. RayBiotech Recent Development
Table 78. Cygnus Technologies Company Detail
Table 79. Cygnus Technologies Business Overview
Table 80. Cygnus Technologies Monoclonal Antibody Production Service Product
Table 81. Cygnus Technologies Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 82. Cygnus Technologies Recent Development
Table 83. Sino Biological Company Detail
Table 84. Sino Biological Business Overview
Table 85. Sino Biological Monoclonal Antibody Production Service Product
Table 86. Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 87. Sino Biological Recent Development
Table 88. BosterBio Company Detail
Table 89. BosterBio Business Overview
Table 90. BosterBio Monoclonal Antibody Production Service Product
Table 91. BosterBio Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 92. BosterBio Recent Development
Table 93. Abeomics Company Detail
Table 94. Abeomics Business Overview
Table 95. Abeomics Monoclonal Antibody Production Service Product
Table 96. Abeomics Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 97. Abeomics Recent Development
Table 98. Merck Company Detail
Table 99. Merck Business Overview
Table 100. Merck Monoclonal Antibody Production Service Product
Table 101. Merck Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Cayman Chemical Company Detail
Table 104. Cayman Chemical Business Overview
Table 105. Cayman Chemical Monoclonal Antibody Production Service Product
Table 106. Cayman Chemical Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 107. Cayman Chemical Recent Development
Table 108. Hycult Biotech Company Detail
Table 109. Hycult Biotech Business Overview
Table 110. Hycult Biotech Monoclonal Antibody Production Service Product
Table 111. Hycult Biotech Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 112. Hycult Biotech Recent Development
Table 113. GenScript Company Detail
Table 114. GenScript Business Overview
Table 115. GenScript Monoclonal Antibody Production Service Product
Table 116. GenScript Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 117. GenScript Recent Development
Table 118. ProMab Company Detail
Table 119. ProMab Business Overview
Table 120. ProMab Monoclonal Antibody Production Service Product
Table 121. ProMab Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 122. ProMab Recent Development
Table 123. R&D Systems Company Detail
Table 124. R&D Systems Business Overview
Table 125. R&D Systems Monoclonal Antibody Production Service Product
Table 126. R&D Systems Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 127. R&D Systems Recent Development
Table 128. Rockland Immunochemicals Company Detail
Table 129. Rockland Immunochemicals Business Overview
Table 130. Rockland Immunochemicals Monoclonal Antibody Production Service Product
Table 131. Rockland Immunochemicals Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 132. Rockland Immunochemicals Recent Development
Table 133. ProteoGenix Company Detail
Table 134. ProteoGenix Business Overview
Table 135. ProteoGenix Monoclonal Antibody Production Service Product
Table 136. ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 137. ProteoGenix Recent Development
Table 138. Evitria Company Detail
Table 139. Evitria Business Overview
Table 140. Evitria Monoclonal Antibody Production Service Product
Table 141. Evitria Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 142. Evitria Recent Development
Table 143. ProteoGenix Company Detail
Table 144. ProteoGenix Business Overview
Table 145. ProteoGenix Monoclonal Antibody Production Service Product
Table 146. ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 147. ProteoGenix Recent Development
Table 148. Beijing Abace Biotechnology Company Detail
Table 149. Beijing Abace Biotechnology Business Overview
Table 150. Beijing Abace Biotechnology Monoclonal Antibody Production Service Product
Table 151. Beijing Abace Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 152. Beijing Abace Biotechnology Recent Development
Table 153. Zoonbio Biotechnology Company Detail
Table 154. Zoonbio Biotechnology Business Overview
Table 155. Zoonbio Biotechnology Monoclonal Antibody Production Service Product
Table 156. Zoonbio Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 157. Zoonbio Biotechnology Recent Development
Table 158. Beijing Biosynthesis Biotechnology Company Detail
Table 159. Beijing Biosynthesis Biotechnology Business Overview
Table 160. Beijing Biosynthesis Biotechnology Monoclonal Antibody Production Service Product
Table 161. Beijing Biosynthesis Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 162. Beijing Biosynthesis Biotechnology Recent Development
Table 163. Cusabio Company Detail
Table 164. Cusabio Business Overview
Table 165. Cusabio Monoclonal Antibody Production Service Product
Table 166. Cusabio Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 167. Cusabio Recent Development
Table 168. ChinaPeptides Company Detail
Table 169. ChinaPeptides Business Overview
Table 170. ChinaPeptides Monoclonal Antibody Production Service Product
Table 171. ChinaPeptides Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 172. ChinaPeptides Recent Development
Table 173. Detaibio Company Detail
Table 174. Detaibio Business Overview
Table 175. Detaibio Monoclonal Antibody Production Service Product
Table 176. Detaibio Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 177. Detaibio Recent Development
Table 178. Atagenix Laboratories Company Detail
Table 179. Atagenix Laboratories Business Overview
Table 180. Atagenix Laboratories Monoclonal Antibody Production Service Product
Table 181. Atagenix Laboratories Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 182. Atagenix Laboratories Recent Development
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Production Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Monoclonal Antibody Production Service Market Share by Type: 2023 VS 2030
Figure 3. Rabbit Monoclonal Antibodies Features
Figure 4. Mouse Monoclonal Antibodies Features
Figure 5. Human Monoclonal Antibodies Features
Figure 6. Others Features
Figure 7. Global Monoclonal Antibody Production Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Monoclonal Antibody Production Service Market Share by Application: 2023 VS 2030
Figure 9. Biotechnology Case Studies
Figure 10. Medical Case Studies
Figure 11. University Case Studies
Figure 12. Others Case Studies
Figure 13. Monoclonal Antibody Production Service Report Years Considered
Figure 14. Global Monoclonal Antibody Production Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Monoclonal Antibody Production Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Monoclonal Antibody Production Service Market Share by Region: 2023 VS 2030
Figure 17. Global Monoclonal Antibody Production Service Market Share by Players in 2023
Figure 18. Global Top Monoclonal Antibody Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Production Service as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Monoclonal Antibody Production Service Revenue in 2023
Figure 20. North America Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Monoclonal Antibody Production Service Market Share by Country (2019-2030)
Figure 22. United States Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Monoclonal Antibody Production Service Market Share by Country (2019-2030)
Figure 26. Germany Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Monoclonal Antibody Production Service Market Share by Region (2019-2030)
Figure 34. China Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Monoclonal Antibody Production Service Market Share by Country (2019-2030)
Figure 42. Mexico Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Monoclonal Antibody Production Service Market Share by Country (2019-2030)
Figure 46. Turkey Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Bon Opus Biosciences Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 49. Biomatik Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 50. ProSci, Inc Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 51. Sino Biological Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 53. RayBiotech Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 54. Cygnus Technologies Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 55. Sino Biological Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 56. BosterBio Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 57. Abeomics Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 58. Merck Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 59. Cayman Chemical Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 60. Hycult Biotech Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 61. GenScript Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 62. ProMab Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 63. R&D Systems Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 64. Rockland Immunochemicals Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 65. ProteoGenix Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 66. Evitria Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 67. ProteoGenix Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 68. Beijing Abace Biotechnology Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 69. Zoonbio Biotechnology Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 70. Beijing Biosynthesis Biotechnology Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 71. Cusabio Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 72. ChinaPeptides Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 73. Detaibio Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 74. Atagenix Laboratories Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Table 1. Global Monoclonal Antibody Production Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Rabbit Monoclonal Antibodies
Table 3. Key Players of Mouse Monoclonal Antibodies
Table 4. Key Players of Human Monoclonal Antibodies
Table 5. Key Players of Others
Table 6. Global Monoclonal Antibody Production Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Monoclonal Antibody Production Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Monoclonal Antibody Production Service Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Monoclonal Antibody Production Service Market Share by Region (2019-2024)
Table 10. Global Monoclonal Antibody Production Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Monoclonal Antibody Production Service Market Share by Region (2025-2030)
Table 12. Monoclonal Antibody Production Service Market Trends
Table 13. Monoclonal Antibody Production Service Market Drivers
Table 14. Monoclonal Antibody Production Service Market Challenges
Table 15. Monoclonal Antibody Production Service Market Restraints
Table 16. Global Monoclonal Antibody Production Service Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Monoclonal Antibody Production Service Market Share by Players (2019-2024)
Table 18. Global Top Monoclonal Antibody Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Production Service as of 2023)
Table 19. Ranking of Global Top Monoclonal Antibody Production Service Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Monoclonal Antibody Production Service Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Monoclonal Antibody Production Service Product Solution and Service
Table 23. Date of Enter into Monoclonal Antibody Production Service Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Monoclonal Antibody Production Service Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Monoclonal Antibody Production Service Revenue Market Share by Type (2019-2024)
Table 27. Global Monoclonal Antibody Production Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Monoclonal Antibody Production Service Revenue Market Share by Type (2025-2030)
Table 29. Global Monoclonal Antibody Production Service Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Monoclonal Antibody Production Service Revenue Market Share by Application (2019-2024)
Table 31. Global Monoclonal Antibody Production Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Monoclonal Antibody Production Service Revenue Market Share by Application (2025-2030)
Table 33. North America Monoclonal Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Monoclonal Antibody Production Service Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Monoclonal Antibody Production Service Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Monoclonal Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Monoclonal Antibody Production Service Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Monoclonal Antibody Production Service Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Monoclonal Antibody Production Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Monoclonal Antibody Production Service Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Monoclonal Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Monoclonal Antibody Production Service Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Monoclonal Antibody Production Service Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Monoclonal Antibody Production Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Monoclonal Antibody Production Service Market Size by Country (2025-2030) & (US$ Million)
Table 48. Bon Opus Biosciences Company Detail
Table 49. Bon Opus Biosciences Business Overview
Table 50. Bon Opus Biosciences Monoclonal Antibody Production Service Product
Table 51. Bon Opus Biosciences Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 52. Bon Opus Biosciences Recent Development
Table 53. Biomatik Company Detail
Table 54. Biomatik Business Overview
Table 55. Biomatik Monoclonal Antibody Production Service Product
Table 56. Biomatik Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 57. Biomatik Recent Development
Table 58. ProSci, Inc Company Detail
Table 59. ProSci, Inc Business Overview
Table 60. ProSci, Inc Monoclonal Antibody Production Service Product
Table 61. ProSci, Inc Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 62. ProSci, Inc Recent Development
Table 63. Sino Biological Company Detail
Table 64. Sino Biological Business Overview
Table 65. Sino Biological Monoclonal Antibody Production Service Product
Table 66. Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 67. Sino Biological Recent Development
Table 68. Thermo Fisher Scientific Company Detail
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Monoclonal Antibody Production Service Product
Table 71. Thermo Fisher Scientific Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. RayBiotech Company Detail
Table 74. RayBiotech Business Overview
Table 75. RayBiotech Monoclonal Antibody Production Service Product
Table 76. RayBiotech Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 77. RayBiotech Recent Development
Table 78. Cygnus Technologies Company Detail
Table 79. Cygnus Technologies Business Overview
Table 80. Cygnus Technologies Monoclonal Antibody Production Service Product
Table 81. Cygnus Technologies Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 82. Cygnus Technologies Recent Development
Table 83. Sino Biological Company Detail
Table 84. Sino Biological Business Overview
Table 85. Sino Biological Monoclonal Antibody Production Service Product
Table 86. Sino Biological Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 87. Sino Biological Recent Development
Table 88. BosterBio Company Detail
Table 89. BosterBio Business Overview
Table 90. BosterBio Monoclonal Antibody Production Service Product
Table 91. BosterBio Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 92. BosterBio Recent Development
Table 93. Abeomics Company Detail
Table 94. Abeomics Business Overview
Table 95. Abeomics Monoclonal Antibody Production Service Product
Table 96. Abeomics Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 97. Abeomics Recent Development
Table 98. Merck Company Detail
Table 99. Merck Business Overview
Table 100. Merck Monoclonal Antibody Production Service Product
Table 101. Merck Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Cayman Chemical Company Detail
Table 104. Cayman Chemical Business Overview
Table 105. Cayman Chemical Monoclonal Antibody Production Service Product
Table 106. Cayman Chemical Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 107. Cayman Chemical Recent Development
Table 108. Hycult Biotech Company Detail
Table 109. Hycult Biotech Business Overview
Table 110. Hycult Biotech Monoclonal Antibody Production Service Product
Table 111. Hycult Biotech Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 112. Hycult Biotech Recent Development
Table 113. GenScript Company Detail
Table 114. GenScript Business Overview
Table 115. GenScript Monoclonal Antibody Production Service Product
Table 116. GenScript Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 117. GenScript Recent Development
Table 118. ProMab Company Detail
Table 119. ProMab Business Overview
Table 120. ProMab Monoclonal Antibody Production Service Product
Table 121. ProMab Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 122. ProMab Recent Development
Table 123. R&D Systems Company Detail
Table 124. R&D Systems Business Overview
Table 125. R&D Systems Monoclonal Antibody Production Service Product
Table 126. R&D Systems Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 127. R&D Systems Recent Development
Table 128. Rockland Immunochemicals Company Detail
Table 129. Rockland Immunochemicals Business Overview
Table 130. Rockland Immunochemicals Monoclonal Antibody Production Service Product
Table 131. Rockland Immunochemicals Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 132. Rockland Immunochemicals Recent Development
Table 133. ProteoGenix Company Detail
Table 134. ProteoGenix Business Overview
Table 135. ProteoGenix Monoclonal Antibody Production Service Product
Table 136. ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 137. ProteoGenix Recent Development
Table 138. Evitria Company Detail
Table 139. Evitria Business Overview
Table 140. Evitria Monoclonal Antibody Production Service Product
Table 141. Evitria Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 142. Evitria Recent Development
Table 143. ProteoGenix Company Detail
Table 144. ProteoGenix Business Overview
Table 145. ProteoGenix Monoclonal Antibody Production Service Product
Table 146. ProteoGenix Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 147. ProteoGenix Recent Development
Table 148. Beijing Abace Biotechnology Company Detail
Table 149. Beijing Abace Biotechnology Business Overview
Table 150. Beijing Abace Biotechnology Monoclonal Antibody Production Service Product
Table 151. Beijing Abace Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 152. Beijing Abace Biotechnology Recent Development
Table 153. Zoonbio Biotechnology Company Detail
Table 154. Zoonbio Biotechnology Business Overview
Table 155. Zoonbio Biotechnology Monoclonal Antibody Production Service Product
Table 156. Zoonbio Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 157. Zoonbio Biotechnology Recent Development
Table 158. Beijing Biosynthesis Biotechnology Company Detail
Table 159. Beijing Biosynthesis Biotechnology Business Overview
Table 160. Beijing Biosynthesis Biotechnology Monoclonal Antibody Production Service Product
Table 161. Beijing Biosynthesis Biotechnology Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 162. Beijing Biosynthesis Biotechnology Recent Development
Table 163. Cusabio Company Detail
Table 164. Cusabio Business Overview
Table 165. Cusabio Monoclonal Antibody Production Service Product
Table 166. Cusabio Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 167. Cusabio Recent Development
Table 168. ChinaPeptides Company Detail
Table 169. ChinaPeptides Business Overview
Table 170. ChinaPeptides Monoclonal Antibody Production Service Product
Table 171. ChinaPeptides Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 172. ChinaPeptides Recent Development
Table 173. Detaibio Company Detail
Table 174. Detaibio Business Overview
Table 175. Detaibio Monoclonal Antibody Production Service Product
Table 176. Detaibio Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 177. Detaibio Recent Development
Table 178. Atagenix Laboratories Company Detail
Table 179. Atagenix Laboratories Business Overview
Table 180. Atagenix Laboratories Monoclonal Antibody Production Service Product
Table 181. Atagenix Laboratories Revenue in Monoclonal Antibody Production Service Business (2019-2024) & (US$ Million)
Table 182. Atagenix Laboratories Recent Development
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Production Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Monoclonal Antibody Production Service Market Share by Type: 2023 VS 2030
Figure 3. Rabbit Monoclonal Antibodies Features
Figure 4. Mouse Monoclonal Antibodies Features
Figure 5. Human Monoclonal Antibodies Features
Figure 6. Others Features
Figure 7. Global Monoclonal Antibody Production Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Monoclonal Antibody Production Service Market Share by Application: 2023 VS 2030
Figure 9. Biotechnology Case Studies
Figure 10. Medical Case Studies
Figure 11. University Case Studies
Figure 12. Others Case Studies
Figure 13. Monoclonal Antibody Production Service Report Years Considered
Figure 14. Global Monoclonal Antibody Production Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Monoclonal Antibody Production Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Monoclonal Antibody Production Service Market Share by Region: 2023 VS 2030
Figure 17. Global Monoclonal Antibody Production Service Market Share by Players in 2023
Figure 18. Global Top Monoclonal Antibody Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Production Service as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Monoclonal Antibody Production Service Revenue in 2023
Figure 20. North America Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Monoclonal Antibody Production Service Market Share by Country (2019-2030)
Figure 22. United States Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Monoclonal Antibody Production Service Market Share by Country (2019-2030)
Figure 26. Germany Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Monoclonal Antibody Production Service Market Share by Region (2019-2030)
Figure 34. China Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Monoclonal Antibody Production Service Market Share by Country (2019-2030)
Figure 42. Mexico Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Monoclonal Antibody Production Service Market Share by Country (2019-2030)
Figure 46. Turkey Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Monoclonal Antibody Production Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Bon Opus Biosciences Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 49. Biomatik Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 50. ProSci, Inc Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 51. Sino Biological Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 53. RayBiotech Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 54. Cygnus Technologies Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 55. Sino Biological Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 56. BosterBio Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 57. Abeomics Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 58. Merck Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 59. Cayman Chemical Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 60. Hycult Biotech Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 61. GenScript Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 62. ProMab Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 63. R&D Systems Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 64. Rockland Immunochemicals Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 65. ProteoGenix Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 66. Evitria Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 67. ProteoGenix Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 68. Beijing Abace Biotechnology Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 69. Zoonbio Biotechnology Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 70. Beijing Biosynthesis Biotechnology Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 71. Cusabio Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 72. ChinaPeptides Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 73. Detaibio Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 74. Atagenix Laboratories Revenue Growth Rate in Monoclonal Antibody Production Service Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232